Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
HAO 
Haoxi Health Technology Limited Class A Ordinary Shares (HAO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: HAO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -18.9% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 3.77M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1.28 | 52 Weeks Range 1.02 - 173.25 | Updated Date 06/29/2025 |
52 Weeks Range 1.02 - 173.25 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.85 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.61% | Operating Margin (TTM) -0.53% |
Management Effectiveness
Return on Assets (TTM) 3.42% | Return on Equity (TTM) 2.92% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -4130603 | Price to Sales(TTM) 0.08 |
Enterprise Value -4130603 | Price to Sales(TTM) 0.08 | ||
Enterprise Value to Revenue 0.63 | Enterprise Value to EBITDA 17.37 | Shares Outstanding 2205800 | Shares Floating 1686284 |
Shares Outstanding 2205800 | Shares Floating 1686284 | ||
Percent Insiders 21.79 | Percent Institutions 5.78 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Haoxi Health Technology Limited Class A Ordinary Shares
Company Overview
History and Background
Haoxi Health Technology Limited focuses on providing online healthcare and related services in China. Its history and specific milestones are not widely publicized as it's a relatively newer entity on the US stock market.
Core Business Areas
- Online Healthcare Services: Haoxi Health Technology Limited facilitates online medical consultations, prescription refills, and health information dissemination through its platform.
Leadership and Structure
The specific leadership team details and organizational structure are not readily available in comprehensive detail. Further research is needed.
Top Products and Market Share
Key Offerings
- Online Medical Consultations: Haoxi provides a platform for online consultations. Market share data is difficult to obtain specifically for Haoxi. Competitors include Ping An Good Doctor (OTCMKTS: PANHF) and JD Health (HKG: 6618).
Market Dynamics
Industry Overview
The online healthcare industry in China is experiencing rapid growth, driven by increasing internet penetration and a growing demand for convenient healthcare solutions.
Positioning
Haoxi Health Technology Limited is positioned as a provider of accessible online healthcare services within the competitive Chinese market. Specific competitive advantages are not definitively stated but are implied through its service offerings.
Total Addressable Market (TAM)
The TAM for online healthcare in China is substantial and growing. Haoxi is positioned to capture a share of this market by providing convenient access to medical services, though specific market share and TAM data are difficult to obtain due to the company's limited reporting and public profile.
Upturn SWOT Analysis
Strengths
- Online Healthcare Platform
- Potential for Growth in China
- Accessibility of Services
Weaknesses
- Limited Public Financial Data
- Intense Competition
- Relatively New Entity
Opportunities
- Expansion of Service Offerings
- Partnerships with Healthcare Providers
- Increase in Internet Penetration in China
Threats
- Regulatory Changes in China
- Competition from Established Players
- Data Security and Privacy Concerns
Competitors and Market Share
Key Competitors
- PANHF
- N/A
Competitive Landscape
Competitive landscape involves balancing limited public financial data with the fact that it is a relatively new entity in an ever-growing industry.
Growth Trajectory and Initiatives
Historical Growth: Insufficient data to analyze historical growth trends.
Future Projections: Future projections are difficult to determine due to a lack of comprehensive analyst coverage.
Recent Initiatives: Information on recent strategic initiatives is not readily available.
Summary
Haoxi Health Technology Limited is a relatively new player in the online healthcare market in China. Its financial performance and market position are challenging to assess due to limited publicly available information. While it has the potential to grow in a rapidly expanding market, it faces intense competition and regulatory uncertainties. Investors should exercise caution due to the lack of comprehensive financial data and limited track record.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Yahoo Finance
- Company filings (if available)
- Industry reports
Disclaimers:
The data provided is based on publicly available information and may not be comprehensive. The analysis is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Haoxi Health Technology Limited Class A Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2008-01-30 | Chairman & CEO Mr. Zhen Fan | ||
Sector Communication Services | Industry Advertising Agencies | Full time employees 30 | Website https://www.haoximedia.com |
Full time employees 30 | Website https://www.haoximedia.com | ||
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. The company offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. It places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. The company serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.